title: Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Fairbank
mesh_terms: D019643:Arthroplasty, Replacement / Q000295:instrumentation*; D018795:Device Approval; D004185:Disability Evaluation; D006801:Humans; D007403:Intervertebral Disc / Q000601:surgery*; D015337:Multicenter Studies as Topic; D011474:Prosthesis Design; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D013122:Spinal Diseases / Q000601:surgery*; D013123:Spinal Fusion; D011795:Surveys and Questionnaires; D009626:Terminology as Topic; D016896:Treatment Outcome; D014481:United States